Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

Bowhead Specialty (BOW) Projected to Announce Quarterly Earnings on Tuesday

Bowhead Specialty logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

Bowhead Specialty (NYSE:BOW - Get Free Report) will likely be issuing its Q3 2026 results before the market opens on Tuesday, November 3rd. Analysts expect the company to post earnings of $0.5110 per share and revenue of $278.64 million for the quarter. Investors can check the company's upcoming Q3 2026 earnings report for the latest details on the call scheduled for Tuesday, November 3, 2026 at 8:30 AM ET.

Bowhead Specialty (NYSE:BOW - Get Free Report) last issued its quarterly earnings data on Monday, August 3rd. The company reported $0.48 earnings per share for the quarter, beating analysts' consensus estimates of $0.47 by $0.01. Bowhead Specialty had a return on equity of 14.05% and a net margin of 10.11%. The business had revenue of $163.86 million during the quarter, compared to analysts' expectations of $278.69 million. On average, analysts expect Bowhead Specialty to post $2.00 EPS for the current fiscal year and $2.44 EPS for the next fiscal year.

Bowhead Specialty Price Performance

BOW opened at $34.10 on Tuesday. The stock's 50-day moving average price is $33.79 and its 200 day moving average price is $28.35. Bowhead Specialty has a 12-month low of $21.21 and a 12-month high of $35.07. The company has a current ratio of 0.49, a quick ratio of 0.49 and a debt-to-equity ratio of 0.31. The firm has a market cap of $1.12 billion, a price-to-earnings ratio of 17.92, a PEG ratio of 1.01 and a beta of -0.07.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on BOW. Deutsche Bank Aktiengesellschaft lowered shares of Bowhead Specialty from a "buy" rating to a "hold" rating and set a $34.00 price target on the stock. in a research note on Monday, August 3rd. JPMorgan Chase & Co. lifted their price objective on shares of Bowhead Specialty from $30.00 to $33.00 and gave the stock a "neutral" rating in a research report on Monday, July 20th. Royal Bank Of Canada lowered Bowhead Specialty from an "outperform" rating to a "sector perform" rating and cut their target price for the stock from $38.00 to $34.00 in a research report on Tuesday, August 4th. Piper Sandler lowered Bowhead Specialty from an "overweight" rating to a "hold" rating and set a $34.00 target price on the stock. in a research report on Monday, August 3rd. Finally, Citigroup cut Bowhead Specialty to a "market perform" rating in a research note on Thursday, September 10th. One research analyst has rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $33.50.

Get Our Latest Stock Analysis on BOW

About Bowhead Specialty

(Get Free Report)

Bowhead Specialty NYSE: BOW is a specialty insurance holding company that provides coverage for complex and hard-to-place risks. Through its insurance subsidiaries, the company primarily underwrites specialty products for businesses and organizations across the United States.

Its offerings include casualty insurance, professional liability coverage, healthcare-related liability products and other specialty lines. Bowhead distributes its products primarily through wholesale insurance brokers, serving customers whose needs may not be met by standard commercial insurance carriers.

The company was established in 2020 and became a publicly traded company in 2024.

Read More

Earnings History for Bowhead Specialty (NYSE:BOW)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Bowhead Specialty Right Now?

Before you consider Bowhead Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.

While Bowhead Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines